By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
India Times NowIndia Times NowIndia Times Now
Notification Show More
Font ResizerAa
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
Reading: TNPCB tells NGT Sun Pharma did not implement proposed expansion in Chengalpattu
Share
India Times NowIndia Times Now
Font ResizerAa
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
Search
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
Have an existing account? Sign In
Follow US

Home » TNPCB tells NGT Sun Pharma did not implement proposed expansion in Chengalpattu

India News

TNPCB tells NGT Sun Pharma did not implement proposed expansion in Chengalpattu

India Times Now Desk
Last updated: September 27, 2026 5:30 pm
India Times Now Desk
Published: September 27, 2026
Share
SHARE


A recent TNPCB inspection found that the unit was in operation but its production was within the existing consented capacity.

A recent TNPCB inspection found that the unit was in operation but its production was within the existing consented capacity.
| Photo Credit: Reuters

The Tamil Nadu Pollution Control Board (TNPCB) has told the National Green Tribunal (NGT) that Sun Pharmaceutical Industries Ltd.’s unit at Sathammai village in Chengalpattu district is currently operating within its existing permitted production capacity and has not undertaken the proposed expansion.

The submission was made in a recent report filed before the southern bench of the NGT following an appeal filed by K.R. Selvaraj Kumar of Meenavar Nala Sangam, challenging the environmental clearance granted to the company for expansion.

Consent to establish

According to the TNPCB report, the unit had originally obtained the Board’s consent to establish in 2005 and consent to operate in 2006 for manufacturing pharmaceutical products with a total production capacity of 25.5 tonnes a month. Subsequent consent orders permitted changes in sewage generation, trade effluent disposal and air pollution control measures, without an increase in the permitted product quantity.

The company later obtained environmental clearance from the Union Ministry of Environment, Forest and Climate Change on March 31, 2022, for increasing its production capacity from 25.5 tonnes per month to 134.082 tonnes per month for active pharmaceutical ingredients within the existing plant. However, the TNPCB said the company had not obtained the Board’s consent to establish or consent to operate for the expansion.

A TNPCB inspection conducted on September 12, 2026, found that the unit was in operation but its production was within the existing consented capacity of 25.5 tonnes a month. The Board also recorded that no expansion activity had been carried out.

The dispute also relates to an earlier NGT order in an original application filed in 2020. The Tribunal had noted violations relating to the unit’s operation without environmental clearance for an earlier expansion and had confirmed an environmental compensation of ₹58.20 lakh for contamination of groundwater and soil. It had also directed payment of an interim compensation of ₹10 crore and asked the TNPCB to assess any additional compensation for operation beyond the permitted pollution load.

The TNPCB report said the company subsequently obtained the 2022 environmental clearance for the proposed expansion and renewed consent from the Board valid up to March 31, 2028, but had not obtained consent specifically for carrying out the expansion.

Published – September 27, 2026 11:00 pm IST



Source link

Why did DMK not take up State autonomy while sharing power in Centre: Palaniswami
Why is the fiscal architecture of municipalities flawed? | Explained
Respect all views except Whatsapp University: Supreme Court in Sabarimala case
Crossing a river into cyber slavery
Kerala Academy of Skills Excellence enters into partnership with Germany’s Deutsche Bahn
TAGGED:NGTsun pharmaTNPCB
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
[mc4wp_form]
Popular News

CPI veteran R. Nallakannu hospitalised in Chennai

India Times Now Desk
India Times Now Desk
February 2, 2026
Datia bypoll: BJP candidate Ashutosh Tiwari files nomination
Crowd tries to grab LPG cylinders from moving tempo in Shaikpet
With CM Vijay opening the Mettur dam, focus turns to longevity of water release
India’s wildlife lodges are making a case for monsoon nature walks
- Advertisement -
Ad imageAd image
Global Coronavirus Cases

Confirmed

0

Death

0

More Information:Covid-19 Statistics
© INDIA TIMES NOW 2026 . All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?